Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

Drug Safety
Acetaminophen May Be Less Heart-Safe Than Previously Thought
04/10/2024

American Physiological Society (APS) News

American Physiological Society (APS) ...
“We found that regular use of acetaminophen at concentrations that are considered safe—equivalent to 500 mg/day—causes numerous signaling pathways inside the heart to be altered,” said Gabriela Rivera, the study’s first author. “These results...
“We found that regular use of acetaminophen at concentrations that are considered safe—equivalent to 500 mg/day—causes numerous signaling pathways inside the heart to be altered,” said Gabriela Rivera, the study’s first author. “These results...
“We found that regular use of...
04/10/2024
Cath Lab Digest

Advertisement

Triglycerides
ACC.24: BRIDGE-TIMI 73a - Study Finds Olezarsen Cuts Triglyceride Levels by About Half
04/10/2024

American College of Cardiology Scientific Sessions News

American College of Cardiology Scient...
“Treatments to reduce high triglycerides are an unmet clinical need,” said Brian Bergmark, MD, the study’s principal investigator. “Based on our study’s results, we can say that the drug worked and appeared to be safe. We tested two doses of...
“Treatments to reduce high triglycerides are an unmet clinical need,” said Brian Bergmark, MD, the study’s principal investigator. “Based on our study’s results, we can say that the drug worked and appeared to be safe. We tested two doses of...
“Treatments to reduce high...
04/10/2024
Cath Lab Digest
Mechanical Circulatory Support
Breakthroughs in Durable Mechanical Circulatory Support (MCS) Devices Aid Heart Failure Patients
04/10/2024

International Society for Heart and Lung Transplantation News

International Society for Heart and L...
“In the next five years, new pumps will have a fully internalized power line and be wirelessly powered from outside the body, just like our iPhones,” said Mandeep R. Mehra, MD, of the Center for Advanced Heart Disease at Brigham Health....
“In the next five years, new pumps will have a fully internalized power line and be wirelessly powered from outside the body, just like our iPhones,” said Mandeep R. Mehra, MD, of the Center for Advanced Heart Disease at Brigham Health....
“In the next five years, new...
04/10/2024
Cath Lab Digest
Cathy Biga, ACC President
ACC News
Cathie Biga is New American College of Cardiology President
04/09/2024

American College of Cardiology News

American College of Cardiology News ...
Cathie Biga, MSN, FACC, has became president of the American College of Cardiology as of April 8, 2024, and made history as the organization’s first non-physician president. She will serve a one-year term representing over 56,000...
Cathie Biga, MSN, FACC, has became president of the American College of Cardiology as of April 8, 2024, and made history as the organization’s first non-physician president. She will serve a one-year term representing over 56,000...
Cathie Biga, MSN, FACC, has...
04/09/2024
Cath Lab Digest

Advertisement

Beta Blockers Post MI
ACC.24: REDUCE-AMI - Beta Blockers May Not Benefit Many Heart Attack Survivors
04/09/2024

American College of Cardiology Scientific Sessions News

American College of Cardiology Scient...
“I think that, following this study, many doctors will not find an indication to routinely treat all their patients with beta blockers following a heart attack,” said Troels Yndigegn, MD, interventional cardiologist at Lund University in...
“I think that, following this study, many doctors will not find an indication to routinely treat all their patients with beta blockers following a heart attack,” said Troels Yndigegn, MD, interventional cardiologist at Lund University in...
“I think that, following this...
04/09/2024
Cath Lab Digest
Vulnerable plaque
ACC.24: PREVENT Trial - Preventive PCI for High-Risk Coronary Plaques Reduces Cardiac Events
04/09/2024

American College of Cardiology Scientific Sessions News

American College of Cardiology Scient...
The trial findings suggest that people with high-risk plaques that are likely to rupture could benefit from PCI as a preemptive measure rather than waiting for a heart attack or other severe reduction in blood flow to occur. The PREVENT trial...
The trial findings suggest that people with high-risk plaques that are likely to rupture could benefit from PCI as a preemptive measure rather than waiting for a heart attack or other severe reduction in blood flow to occur. The PREVENT trial...
The trial findings suggest that...
04/09/2024
Cath Lab Digest
Hypertension
ACC.24: Trial Reports Mixed Results with Nerve Ablation for High Blood Pressure
04/09/2024

American College of Cardiology Scientific Sessions News

American College of Cardiology Scient...
“We saw a modest but statistically significant difference in the primary endpoint, but there were no significant differences in other measures of blood pressure, including office systolic or diastolic blood pressure,” said David E. Kandzari,...
“We saw a modest but statistically significant difference in the primary endpoint, but there were no significant differences in other measures of blood pressure, including office systolic or diastolic blood pressure,” said David E. Kandzari,...
“We saw a modest but...
04/09/2024
Cath Lab Digest

Advertisement

aortic stenosis
ACC.24: DEDICATE-DZHK6 Trial Finds TAVR Non-Inferior to SAVR for Low-Risk Patients
04/09/2024

American College of Cardiology Scientific Sessions News

American College of Cardiology Scient...
“We can now provide strong data that in this low-risk patient population, you could very safely offer TAVR vs. SAVR,” said Moritz Seiffert, MD, professor of cardiology at BG University Hospital Bergmannsheil, Ruhr University Bochum in Bochum,...
“We can now provide strong data that in this low-risk patient population, you could very safely offer TAVR vs. SAVR,” said Moritz Seiffert, MD, professor of cardiology at BG University Hospital Bergmannsheil, Ruhr University Bochum in Bochum,...
“We can now provide strong data...
04/09/2024
Cath Lab Digest
angina
ACC.24: ORBITA-COSMIC - Coronary Sinus Reducer Relieves Angina, But How It Works Remains Unclear
04/09/2024

American College of Cardiology Scientific Sessions News

American College of Cardiology Scient...
The trial focused on patients with angina due to plaque buildup in the coronary arteries that is not adequately controlled with available treatments. The CSR is an hourglass-shaped stent designed to narrow the vein that collects blood from...
The trial focused on patients with angina due to plaque buildup in the coronary arteries that is not adequately controlled with available treatments. The CSR is an hourglass-shaped stent designed to narrow the vein that collects blood from...
The trial focused on patients...
04/09/2024
Cath Lab Digest
refractory angina
ACC.24: Shockwave Reducer Demonstrates Consistent, Positive Results in ‘Real-World’ Study
04/09/2024

Shockwave Medical News

Shockwave Medical News
REDUCER-I is a post-market, multi-center, observational study designed to collect long-term outcomes on Shockwave Reducer in a large, ‘real-world’ population of 400 patients.
REDUCER-I is a post-market, multi-center, observational study designed to collect long-term outcomes on Shockwave Reducer in a large, ‘real-world’ population of 400 patients.
REDUCER-I is a post-market,...
04/09/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Subscriber

Cath Lab Digest Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use